(updated 13 November 2008)
Proprietary names link to more details below
| Proprietary name | Generic name | Manufacturer | Proposed BNF section |
|---|---|---|---|
| Doribax | Doripenem | Janssen-Cilag | 5.1.2 |
| Relistor | Methylnaltrexone | Wyeth | 1.6 |
| Toctino | Alitretinoin | Basilea | 13.5.1 |
| Volibris | Ambrisentan | GSK | 2.5.1 |
Doribax® (Janssen-Cilag)![]()
![]()
Intravenous infusion, powder for reconstitution, doripenem (as monohydrate), net price 500-mg vial = £15.11
BNF section 5.1.2. For the treatment of hospital-acquired pneumonia (including ventilator-associated pneumonia), complicated intra-abdominal infections, and complicated urinary-tract infections in adults
Relistor® (Wyeth)![]()
![]()
Injection, methylnaltrexone 20 mg/mL, net price 0.6 mL vial = £21.05, 7-vial pack = £147.35. For subcutaneous injection
BNF section 1.6. Laxatives. For the treatment of opioid-induced constipation in advanced illness patients who are receiveing palliative care when response to usual laxative therapy is inadequate
Toctino® (Basilea)![]()
![]()
Capsules, alitretinoin 10 mg (brown), net price 30-cap pack = £411.43; 30 mg (red-brown), 30-cap pack = £411.43. Label: 10, patient information leaflet, 21
BNF section 13.5.1. For severe, refractory chronic hand eczema
Volibris® (GSK)![]()
![]()
Tablets, f/c, ambrisentan 5 mg (pale pink), net price 30-tab pack = £1651.07; 10 mg (dark pink), 30-tab pack = £1651.07
BNF section 2.5.1. For the treatment of pulmonary arterial hypertension under specialist supervision